Benzanil Gel
1. Disclaimer
This information is provided for educational and general informational purposes only and is not a substitute for diagnosis, medical advice, prescribing, or the official product leaflet. Benzanil should be used according to the instructions supplied with the product and the advice of a qualified healthcare professional, particularly in children, pregnancy, breastfeeding, extensive or damaged skin, suspected treatment failure, or severe infestation.
We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. Readers are responsible for independently verifying the information before relying on it.
2. Summary
Benzanil is a topical antiparasitic gel marketed in Egypt for the treatment of scabies and pediculosis (lice). Available product information identifies the formulation as benzyl benzoate 10% plus benzyl alcohol 1%, supplied as an 80-g topical gel manufactured by El Nile Co. for Pharmaceuticals and Chemical Industries, Egypt. Benzyl benzoate is the principal antiparasitic ingredient, while benzyl alcohol is included in the formulation and may provide local anaesthetic/symptomatic effects.
3. Brand Name
Benzanil Gel
4. Category
Topical scabicide and pediculicide (antiparasitic agent).
Benzyl benzoate is classified as a topical antiparasitic, scabicidal and pediculocidal agent; its ATC classification is P03AX01.
5. Active Ingredient
Each 100 g of the available Benzanil gel formulation is reported to contain:
- Benzyl benzoate 10 g (10% w/w)
- Benzyl alcohol 1 g (1% w/w)
Reported excipients include Carbopol/Carbopol 940, isopropyl myristate, triethanolamine, polysorbate 80, propylene glycol, isopropyl alcohol, glycerol, and potassium hydroxide. The detailed excipient list is based on the available Benzanil product leaflet material rather than a currently accessible official EDA electronic label.
6. Pharmaceutical Form & Strength
Pharmaceutical form: Topical gel.
Strength: Benzyl benzoate 10% w/w + benzyl alcohol 1% w/w.
Pack size: Tube containing 80 g of gel.
7. Manufacturer & Marketing Authorization Holder
Manufacturer: El Nile Co. for Pharmaceuticals and Chemical Industries, Cairo, Egypt.
Historical Egyptian registration information lists El Nile, Egypt as both the manufacturer and the marketing/registration entity for Benzanil gel. Current public Egyptian market listings continue to identify El Nile as the manufacturer. I could not independently verify a currently displayed EDA electronic record confirming the present-day MAH field separately from the manufacturer; therefore, no stronger claim is made here.
8. Mechanism of Action
Benzyl benzoate exerts antiparasitic effects by acting on the nervous system of mites and lice, ultimately causing their death. Its precise molecular mechanism in the parasites has not been completely established. Benzyl benzoate also has activity against mite eggs, although ovicidal activity is not considered sufficiently reliable to eliminate the need for repeat treatment in many regimens.
Benzyl alcohol has local anaesthetic properties and may contribute to reduction of itching, burning, or stinging, but it is not the principal scabicidal component of the formulation.
9. Spectrum of Activity
Benzanil is intended for Sarcoptes scabiei infestation (scabies) and human lice, with the available product information specifically identifying head and pubic lice.
Benzyl benzoate preparations are used internationally against scabies and pediculosis, although concentrations, formulations, treatment schedules, and licensing vary between countries. It is not appropriate to assume that every benzyl-benzoate product has identical indications or dosing instructions.
10. Pharmacokinetics
The older Benzanil leaflet states that information on percutaneous absorption was unavailable. Current evidence shows that benzyl benzoate can cross the skin, and absorption may increase substantially with conditions such as occlusion. After absorption, benzyl benzoate is rapidly hydrolysed to benzoic acid and benzyl alcohol; subsequent metabolism includes formation of hippuric acid, which is eliminated in urine. The precise pharmacokinetic profile of the marketed Benzanil gel itself has not been established in a modern, product-specific clinical study.
11. Indications
Benzanil is used for:
- Scabies
- Pediculosis (lice), including head and pubic lice
The Egyptian National Antimicrobial Formulary also recognizes topical benzyl benzoate for the treatment of both scabies and pediculosis.
12. Administration
Route: Topical use only.
Scabies
Available Benzanil product information describes application on three consecutive nights, with cleansing before each application. Modern clinical guidance generally describes benzyl benzoate treatment as application over the affected body surface for 2–3 consecutive days, commonly followed by a repeat treatment about one week later depending on the formulation and treatment protocol. Consequently, the exact instructions supplied with the current Benzanil package should take precedence over dosing schedules intended for other benzyl-benzoate formulations.
Treatment should cover the appropriate body areas thoroughly, including commonly missed areas such as the hands, between the fingers, genital area, and beneath the nails when indicated. Eyes and mucous membranes must be avoided.
Close household contacts should be assessed and, when indicated, treated concurrently because asymptomatic contacts can maintain transmission.
Pediculosis
The available Benzanil leaflet describes application to the affected area followed by a 24-hour contact period. Because lice-treatment regimens vary substantially according to formulation and concentration, the current package leaflet or clinician/pharmacist instructions should be followed rather than substituting instructions for another benzyl-benzoate product.
13. Method of Preparation
Benzanil is supplied as a ready-to-use pharmaceutical gel.
No preparation, dilution, or compounding by the patient is required. It should not be diluted or mixed with other products unless specifically directed by a healthcare professional.
14. Contraindications
- Known hypersensitivity to benzyl benzoate, benzyl alcohol, or any other component of the formulation.
- The preparation should not be applied to the eyes or mucous membranes.
- Application to markedly inflamed, severely damaged, or secondarily infected skin requires medical advice because benzyl benzoate can aggravate irritation.
15. Warnings & Precautions
Benzyl benzoate can cause burning, stinging, itching, redness, or other skin irritation, particularly when applied to inflamed or excoriated skin. Avoid contact with the eyes and mucous membranes.
Benzanil is for external use only and must not be swallowed. Excessive application, repeated inappropriate use, or significant ingestion can result in systemic toxicity, including neurological symptoms and, in severe poisoning, convulsions.
If accidental ingestion occurs, do not induce vomiting. Rinse the mouth, seek urgent medical or poison-control advice, and do not attempt gastric lavage at home. Management of significant poisoning is medically supervised and is primarily supportive, with treatment of seizures or other complications when required.
Avoid unnecessary occlusive dressings over treated areas unless specifically instructed.
Children require particular caution because benzyl benzoate may cause greater irritation or toxicity when improperly used. Age-specific use varies among formulations and guidelines; treatment of young children should therefore be supervised by a healthcare professional.
16. Drug Interactions
No clinically important systemic drug interactions are well established for topical benzyl benzoate. However, absence of documented interactions does not prove that interactions are impossible.
Concomitant application of other potentially irritating topical medicines or chemicals may increase local irritation and should be avoided unless recommended by a healthcare professional.
17. Side Effects
Possible adverse effects include:
- Burning or stinging
- Itching
- Redness and skin irritation
- Eczematous or inflammatory skin reactions
- Eye irritation following accidental contact
Excessive exposure or poisoning may produce neurological manifestations, including abnormal movements, loss of consciousness, or convulsions.
Persistent or worsening symptoms after treatment should not automatically be interpreted as treatment failure because post-scabies itching may persist for 1–2 weeks or longer even after successful eradication of the mites.
18. Use in Special Populations
Pregnancy
Available evidence has not demonstrated a clear increase in adverse pregnancy outcomes with topical benzyl benzoate, but pregnancy-specific clinical data remain limited. Therefore, the previous categorical statement that Benzanil is simply “safe during pregnancy” is too definitive.
Current specialist guidance permits 10% benzyl benzoate as a treatment option in pregnancy in some circumstances, while other guidelines prefer permethrin because of its better-established safety profile. Treatment during pregnancy should therefore be selected with professional advice.
Breastfeeding
Adequate studies establishing infant exposure through breast milk are lacking. Benzyl benzoate should therefore be used during breastfeeding only when appropriate and with professional guidance. If treatment involves the breast or nipple, the treated material should be removed before breastfeeding and the treatment reapplied afterward as directed.
Children
Benzyl benzoate can be used in children with appropriately selected formulations and concentrations in some treatment protocols, but young children are more susceptible to irritation and dosing errors. Specific age restrictions and dilution requirements vary by product and guideline. Benzanil 10% gel should not automatically be substituted for another benzyl-benzoate preparation in infants or very young children without medical advice.
Older adults
Older adults may have drier or more fragile skin and may experience greater irritation. Careful application and monitoring are advisable.
19. Storage Conditions
The available Benzanil product information specifies storage at below 30°C, in a well-closed container and protected from light. Keep out of the reach of children.
The current package label should be followed if its storage instructions differ from older product information.
20. Additional Sections
Household and environmental measures
Scabies is spread primarily through prolonged skin-to-skin contact, and household/close contacts should be assessed and treated simultaneously when indicated. Clothing, bedding, and towels used recently by an affected person should be appropriately handled according to current scabies-control guidance. Fumigation of living areas is unnecessary.
Treatment failure and persistent itching
Failure to improve can result from incorrect application, untreated contacts, reinfestation, inadequate contact time, or another diagnosis. Persistent itching alone does not necessarily mean that live mites remain. New burrows or continuing active lesions after an appropriate treatment course warrant medical reassessment.
Product-specific dosing versus generic benzyl benzoate dosing
Benzyl benzoate is available internationally in several concentrations and formulations, commonly 10–25%. Instructions for one product must not automatically be transferred to another product. Benzanil's exact package directions should therefore be used for the marketed gel.
21. Frequently Asked Questions (FAQ)
What is Benzanil Gel used for?
It is a topical antiparasitic treatment used for scabies and pediculosis (lice), according to the available Benzanil product information.
What are the active ingredients?
The available Benzanil formulation contains benzyl benzoate 10% and benzyl alcohol 1%.
Can Benzanil be used for head lice?
Available product information identifies pediculosis capitis as an indication. However, benzyl-benzoate lice regimens vary by formulation, so the Benzanil package instructions should be followed.
Can Benzanil be used during pregnancy?
Topical benzyl benzoate has been used during pregnancy, and available observational evidence has not demonstrated a clear increased risk of adverse pregnancy outcomes. Nevertheless, evidence is limited, and treatment choice should be discussed with a healthcare professional; permethrin is often preferred when appropriate.
Is Benzanil safe while breastfeeding?
Infant exposure through breast milk has not been adequately studied. Professional guidance is advisable, especially when the breasts or nipples are involved.
What should be done if Benzanil gets into the eyes?
Immediately rinse the eyes thoroughly with clean water or saline. Persistent pain, redness, visual symptoms, or significant exposure requires medical assessment.
What if Benzanil is swallowed?
Do not induce vomiting. Rinse the mouth and obtain urgent medical or poison-control advice because significant ingestion can cause systemic toxicity, including neurological effects and seizures.
22. References
- Egyptian Drug Authority (EDA). Egyptian National Antimicrobial Formulary, 2023 — Benzyl Benzoate monograph.
- World Health Organization (WHO). Scabies — treatment and household-control guidance.
- Centers for Disease Control and Prevention (CDC). Ectoparasitic Infections: Scabies and lice treatment guidance.
- French Society of Dermatology / Centre de Preuves en Dermatologie. Updated recommendations for scabies in pregnancy and breastfeeding, January 2026.
- British Association for Sexual Health and HIV (BASHH). National Guideline on the Management of Scabies in Adults, 2025.
- Clinical practice guidelines for the diagnosis and treatment of scabies. International Journal of Dermatology, 2024.
- Mayo Clinic / Micromedex. Benzyl benzoate topical route — adverse effects and precautions; updated February 2026.
- PubChem, National Library of Medicine. Benzyl benzoate — pharmacokinetics, metabolism, mechanism and toxicology.
- Available Benzanil product leaflet material. Benzanil Gel, El Nile Co.; formulation, 80-g pack, indications, product-specific administration and storage information.
- Egyptian pharmaceutical market listings. Current online listings continue to identify Benzanil Gel 80 g, El Nile, Egypt, with benzyl alcohol + benzyl benzoate. These listings are market references rather than substitutes for an official current EDA label.